Enter your terms above and click the 'Search' button.

Showing articles 0 to 2 of 2 Filter Applied: mild cognitive impairment (Click to remove) Controversy and Progress in Alzheimers Disease - FDA Approval of Aducanumab NEJM 385:doi:10.1056/NEJMp2111320, Rabinovici, G.D., 2021 Potentially Reversible Autoimmune Limbic ncephalitis with Neuronal Potassium Channel Antibody Neurol 62:1177-1182,1040, Thieben,M.J.,et al, 2004 Showing articles 0 to 2 of 2